跳至主要内容
临床试验/NCT06256783
NCT06256783招募中早期 1 期

The Efficacy and Safety of Chinese Herbal Compound Baozhu Keli in the Treatment of Ovarian Aging: A Multicenter and Prospective Study.

Tongji Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
招募中
入组人数
100
试验地点
1
主要终点
the recovery rate of ovarian function

研究概览

简要总结

Ovarian aging (OA) seriously affects the physical and mental health of women. Nowadays, Chinese herbs have huge appeal and potential in treating OA. We have created a new Chinese herbal combination Baozhu Keli, whereas its safety and efficacy still need to be validated. Hence, we will perform a population-based, multicenter study to confirm the safety and efficacy of Baozhu Keli in therapy of OA. We aim to provide a solid evidence for TCM in therapy of OA.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • The age range of patient is 18-40 years old.
  • The diagnostic criteria for ovarian aging.
  • Sign the informed consent form.

排除标准

  • Patient is known to be allergic or unsuitable for the Chinese herbal compound.
  • Women who are pregnant and lactating.
  • Abnormal uterine bleeding, except ovulation disorders.
  • Women is taking hormone drugs and has stopped taking them within 3 months;
  • Women with endometriosis, myadenosis, submucosal fibroids or the size of non- submucosal fibroids is more than 4 cm.
  • The nature of pelvic mass is unknown.
  • Women with polycystic ovary syndrome, hyperprolactinemia, hyperandrogenemia, diabetes, thyroid and adrenal dysfunction and other endocrine diseases affecting ovulation.
  • Patients with serious primary diseases such as cardiovascular, liver, kidney, lung, biliary, hematopoietic system (Hb<90g/L) and malignant tumor, and psychiatric patients.
  • Patients are participating in other clinical trials or have participated in other clinical trials within the last month.
  • Unsuitable for the study evaluated by the investigator.

研究组 & 干预措施

Treatment group

Experimental

Once enrolled, participants will be administrated Baozhu Keli and followed by a 3-month medication cycle. The usage of this herbal compound is to take orally twice a day(two sacks per). Add it to about 200ml warm water and take it half an hour before breakfast in the morning and half an hour before bedtime in the evening except menstrual period.

干预措施: Baozhu Keli (Drug)

结局指标

主要结局

the recovery rate of ovarian function

时间窗: 6 months

evaluations of ovarian reserve are mainly based on the levels of AMH, basal serum FSH, and AFC. If the serum FSH level is lower than 10 mIU/mL, the serum AMH level is greater than 1.1 ng/mL,or AFC is more than 6 after treatment, it is considered effective. In addition, an improvement of more than 50% in these indicators after treatment can also be considered effective.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jinjin Zhang

Professor

Tongji Hospital

研究点 (1)

Loading locations...

相似试验